MANTELLE JUAN A 4

4 · NOVEN PHARMACEUTICALS INC · Filed Aug 24, 2005

Form 4

Period: 2005-08-24

VP and Chief Technical Officer

Transactions

Exercise/Conversion
Common Stock ($.0001 Par Value)
2005-08-24$4.19/sh+1,500$6,285→ 23,346 total
Sale
Common Stock ($.0001 Par Value)
2005-08-24$15.99/sh−1,250$19,988→ 21,846 total
Exercise/Conversion
Stock Option (Right to Buy)
2005-08-24−1,250→ 0 total
Exercise: $5.56From: 2005-08-24Exp: 2006-06-21→ Common Stock ($.0001 Par Value) (1,250 underlying)
Sale
Common Stock ($.0001 Par Value)
2005-08-24$15.99/sh−1,500$23,985→ 21,846 total
Exercise/Conversion
Common Stock ($.0001 Par Value)
2005-08-24$5.56/sh+1,250$6,950→ 23,096 total
Exercise/Conversion
Stock Option (Right to Buy)
2005-08-24−1,500→ 0 total
Exercise: $4.19From: 2005-08-24Exp: 2005-12-13→ Common Stock ($.0001 Par Value) (1,500 underlying)

Footnotes (2)

[F1]10% exercisable after 12/14/1999; 20% exercisable after 12/14/2000; 20% exercisable after 12/14/2001; 25% exercisable after 12/14/2002; and 25% exercisable after 12/14/2003. The reporting person has transferred 10,000 of such options to his ex-wife pursuant to a domestic relations order.
[F2]10% exercisable after 6/22/2000; 20% exercisable after 6/22/2001; 20% exercisable after 6/22/2002; 25% exercisable after 6/22/2003; and 25% exercisable after 6/22/2004. The reporting person has transferred 12,500 of such options to his ex-wife pursuant to a domestic relations order.

Documents

1 file